MedTrace Logo

Use of Omegaven Fish Oil Emulsion for Parenteral Nutrition Associated Liver Disease in Infants and Children

NCT01194063 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2026-04-03

No results posted yet for this study

Summary

Use of a fish oil emulsion to decrease liver disease due to long term intravenous nutrition.

Conditions

  • Cholestasis

Interventions

DRUG

Omega-3 fish oil lipid emulsion

daily intravenous administration of Omegaven fish oil emulsion

Sponsors & Collaborators

  • Kapiolani Medical Center For Women & Children

    lead OTHER

Principal Investigators

  • Lynn M Iwamoto, MD · Kapiolani Medical Center For Women & Children

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-20
Primary Completion
2018-11-30
Completion
2019-01-15
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01194063 on ClinicalTrials.gov